NO970885L - Oligonukleotid konjugater, sammensetninger og fremgangsmåter for splitting av ribonukleotider - Google Patents

Oligonukleotid konjugater, sammensetninger og fremgangsmåter for splitting av ribonukleotider

Info

Publication number
NO970885L
NO970885L NO970885A NO970885A NO970885L NO 970885 L NO970885 L NO 970885L NO 970885 A NO970885 A NO 970885A NO 970885 A NO970885 A NO 970885A NO 970885 L NO970885 L NO 970885L
Authority
NO
Norway
Prior art keywords
oligonucleotide
ribonucleotides
splitting
compositions
methods
Prior art date
Application number
NO970885A
Other languages
English (en)
Norwegian (no)
Other versions
NO970885D0 (no
Inventor
Dieter Huesken
Heinz Moser
Robert Haener
Jonathan Hall
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of NO970885D0 publication Critical patent/NO970885D0/no
Publication of NO970885L publication Critical patent/NO970885L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813—Hybridisation assays
    • C12Q1/6816—Hybridisation assays characterised by the detection means
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0042—Photocleavage of drugs in vivo, e.g. cleavage of photolabile linkers in vivo by UV radiation for releasing the pharmacologically-active agent from the administered agent; photothrombosis or photoocclusion
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Biochemistry (AREA)
  • Virology (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Epidemiology (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO970885A 1994-09-02 1997-02-27 Oligonukleotid konjugater, sammensetninger og fremgangsmåter for splitting av ribonukleotider NO970885L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH269494 1994-09-02
PCT/EP1995/003408 WO1996007667A1 (de) 1994-09-02 1995-08-30 Oligonukleotidkonjugate, zusammensetzungen und verfahren zur spaltung von ribonukleinsäuren

Publications (2)

Publication Number Publication Date
NO970885D0 NO970885D0 (no) 1997-02-27
NO970885L true NO970885L (no) 1997-04-25

Family

ID=4239485

Family Applications (1)

Application Number Title Priority Date Filing Date
NO970885A NO970885L (no) 1994-09-02 1997-02-27 Oligonukleotid konjugater, sammensetninger og fremgangsmåter for splitting av ribonukleotider

Country Status (8)

Country Link
EP (1) EP0778845A1 (ja)
JP (1) JPH10505353A (ja)
AU (1) AU3519095A (ja)
CA (1) CA2197785A1 (ja)
FI (1) FI970696A0 (ja)
HU (1) HUT77034A (ja)
NO (1) NO970885L (ja)
WO (1) WO1996007667A1 (ja)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5798491A (en) * 1993-06-09 1998-08-25 Board Of Regents, The University Of Texas System Multi-mechanistic chemical cleavage using certain metal complexes
US5714328A (en) * 1995-06-07 1998-02-03 Board Of Regents, The University Of Texas System RNA photocleavage using texaphyrins
US6022959A (en) * 1996-08-20 2000-02-08 Pharmacyclics, Inc. Nucleic acids internally-derivatized with a texaphyrin metal complex and uses thereof
WO1998007733A1 (en) * 1996-08-20 1998-02-26 Pharmacyclics, Inc. Nucleic acids internally-derivatized with a texaphyrin metal complex and uses thereof
US6255476B1 (en) * 1999-02-22 2001-07-03 Pe Corporation (Ny) Methods and compositions for synthesis of labelled oligonucleotides and analogs on solid-supports
KR101040700B1 (ko) * 2006-11-16 2011-06-10 주식회사 엘지화학 테레프탈알데히드의 정제방법
PE20090044A1 (es) 2007-04-06 2009-01-23 Neurocrine Biosciences Inc Antagonistas del receptor de la hormona liberadora de gonadotropina y procedimientos relacionados con los mismos
WO2008124614A1 (en) 2007-04-06 2008-10-16 Neurocrine Biosciences, Inc. Gonadotropin-releasing hormone receptor antagonists and methods relating thereto

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5559207A (en) * 1989-03-06 1996-09-24 Board Of Regents, University Of Texas Texaphyrin metal complex mediated ester hydrolysis

Also Published As

Publication number Publication date
NO970885D0 (no) 1997-02-27
CA2197785A1 (en) 1996-03-14
AU3519095A (en) 1996-03-27
FI970696A (fi) 1997-02-19
EP0778845A1 (de) 1997-06-18
FI970696A0 (fi) 1997-02-19
WO1996007667A1 (de) 1996-03-14
HUT77034A (hu) 1998-03-02
JPH10505353A (ja) 1998-05-26

Similar Documents

Publication Publication Date Title
Peck-Miller et al. Kinetics of the processing of the precursor to 4· 5 S RNA, a naturally occurring substrate for RNase P from Escherichia coli
BR9809433A (pt) Moléculas de dna enzimáticas
Green et al. In vitro complementation analysis localizes 23S rRNA posttranscriptional modifications that are required for Escherichia coli 50S ribosomal subunit assembly and function.
Krol et al. The nuclear 5S RNAs from chicken, rat and man. US RNAs are encoded by multiple genes
ATE324464T1 (de) Eine in kaskaden verlaufende vervielfältigungsreaktion von nukleinsäuren
Harada et al. Specific cleavage of tRNA by nuclease S1
FI972333A (fi) Entsymaattiset DNA-molekyylit
DE69736598D1 (de) Ribonukleaseresistente rna präparation und seine verwendung
EP2009102A3 (en) Random mutagenesis and amplification of nucleic acid
ATE272110T1 (de) Isolierung von nukleinsäuren
NO975731L (no) Katalytisk DNA
DE69838449D1 (de) Aminooxy-modifizierte oligonukleotide
BR9610511B1 (pt) construções de dna, úteis em terapia genética, compreendendo ao menos uma sequência nucléica de interesse e composição farmacêutica.
IL98543A (en) Endonuclease and its use in the cleavage of a target nucleic acid sequence
BR9904449A (pt) Processo para o preparo de ácido pantotênico através de amplificação de sequências de nucleotìdeos, as quais codificam a redutase de cetopantoato
NO970885L (no) Oligonukleotid konjugater, sammensetninger og fremgangsmåter for splitting av ribonukleotider
NO975313D0 (no) Hydrolyse og fotospaltning av nukleinsyre ved bruk av metallkompleks
Denoya et al. Mono-and dimethylating activities and kinetic studies of the ermC 23 S rRNA methyltransferase
Singh et al. Yeast DNA primase and DNA polymerase activities. An analysis of RNA priming and its coupling to DNA synthesis.
NO972868L (no) Oligonukleotid-dendrimer konjugater
ID27760A (id) Poliketida-poliketida, pembuatannya, dan bahan-bahan untuk penggunaannya
WO1998054313A3 (en) Dna methyltransferase genomic sequences and antisense oligonucleotides
ATE242261T1 (de) Fluoreszend-konjugaten von nukleosiden und von nukleotiden, ihrer verfahren zur herstellung und ihrer verwendungen
Briand et al. Stucture of the amino-acid accepting 3'-end of high-molecular-weight eggplant mosaic virus RNA.
WO1994000572A3 (en) Gene for ataxia-telangiectasia complementation group d (atdc)